INS and diabetes mellitus: Study participants shall be randomised to one of the study arms using minimisation on age (18–40 years; 41–60 years), gender, duration of diabetes (≤ 5 years; > 5 years), and medications (oral + basal insulin; oral + basal/bolus insulin).